Syndax Pharmaceuticals (SNDX) Capital Expenditures Growth (1y) (2016 - 2018)

Syndax Pharmaceuticals (SNDX) Capital Expenditures Growth (1y) (2016 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn - 38.18%
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn -27.93%
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn 227.76%
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn 0.57%
7 Belite Bio 62.88 Bn 62.88 Bn - -
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn 143.40%
10 Syndax Pharmaceuticals 1.84 Bn 1.49 Bn 53.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 -66.67%
Sep 30, 2017 -98.18%
Sep 30, 2016 323.08%